Compugen Ltd. (CGEN)

Compugen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-18.75	-33.69	-34.2	-29.7	-27.34
Depreciation & Amortization	0.48	0.48	0.46	0.72	0.99
Share-Based Compensation	3.55	4.33	4.28	2.77	2.41
Other Operating Activities	-21.16	-5.23	6.78	-2.11	-3.95
Operating Cash Flow	-35.89	-34.11	-22.69	-28.32	-27.89
Capital Expenditures	-0.17	-0.49	-0.29	-0.12	0.23
Change in Investments	35.68	37.55	6.91	-82.05	5.1
Investing Cash Flow	35.51	37.06	6.62	-82.17	5.33
Share Issuance / Repurchase	3.08	0.35	16.84	108.46	25.93
Financing Cash Flow	3.08	0.35	16.84	108.46	25.93
Exchange Rate Effect	0.13	-0.39	-0.06	0	0
Net Cash Flow	2.83	2.91	0.7	-2.03	3.37
Free Cash Flow	-36.06	-34.6	-22.98	-28.44	-27.66
Free Cash Flow Margin	-107.77%	-461.31%	-383.00%	-1422.10%	-
Free Cash Flow Per Share	-0.41	-0.40	-0.27	-0.36	-0.43

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).